Back to today’s briefing

Story perspectives

Seer Unveils Proteograph ONE for Early Cancer Detection

10/3/2025

50 8 Full Breakdown

Summary

Story summary

Seer launched Proteograph ONE, a plasma proteome platform advancing population-scale personalized medicine.
Engineered nanoparticles and automated workflows deepen protein analysis and reveal low-abundance proteins.
In collaboration with Korea University, it will analyze 20,000 plasma samples for early cancer biomarkers in young adults.
The system processes up to 80 samples in about 5 hours while preserving data quality.

1 of 1

Story summary

Seer launched Proteograph ONE, a plasma proteome platform advancing population-scale personalized medicine.
Engineered nanoparticles and automated workflows deepen protein analysis and reveal low-abundance proteins.
In collaboration with Korea University, it will analyze 20,000 plasma samples for early cancer biomarkers in young adults.
The system processes up to 80 samples in about 5 hours while preserving data quality.